Type 2 & other diabetes

Social determinants of health and progression to cardio–renal–metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study

Diabetes Obes MetabPublished Prospective cohort study

Authors' conclusion

Unfavourable SDHs were associated with increased risks of progression from prediabetes. Resource allocation and lifestyle promotion should be prioritised for those with unfavourable SDHs to mitigate disparities in progression to CRMM and death in diabetes care, especially in the early disease stage.

Study context

Population
Participants with prediabetes, free of cardio-renal-metabolic disease (CRMD) (T2D, CVD, CKD) at baseline, UK Biobank
Participants
37,098 participants
Exposure
Unfavourable vs medium vs favourable SDH score
Outcome
Transitions from prediabetes to first CRMD, CRMM (≥2 CRMDs) and death (five transition paths)
Methodological detailsmultistate models, mediation analysis
  • Multistate models
  • Mediation analysis

Main finding

As reported in the abstract

Transition stages from prediabetes to CRMD, CRMM and death
  • Unfavourable vs favourable SDH: consistently elevated risks for different transition stages, except cardio-renal-metabolic multimorbidity (CRMM)-to-death transition

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
CKD-to-death transitionUnfavourablevs FavourableHighest risk among disease-specific associations2.22 (1.16–4.26)

Mediation by lifestyle

Lifestyle partially mediated the associations; mediation proportion at each stage
less than 20%

CKD-to-death transition

Unfavourable SDHs disproportionally increased the risks of three CRMDs

Original publication

Social determinants of health and progression to cardio–renal–metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study. Diabetes Obes Metab. Published 27 August 2025. doi:10.1111/dom.70067

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.